AXT Brings inviCRO’s Preclinical Medical Imaging Products to Australia

AXT has recently bolstered their preclinical and translational imaging products portfolio with the addition of inviCRO’s innovative software platforms. These products empower users with increased visualisation and analytical capabilities as well as more efficient data and project management facilities.

inviCRO is a US-based company that specializes in providing translational imaging services and software for drug discovery and development efforts with applications ranging from tissue to human and from target identification to Phase 3 trials across the entire electromagnetic spectrum of imaging techniques.

Since 2009, they have completed more than 850 imaging trials for pharmaceutical groups, leveraging their internally developed software platforms. This demonstrated ability is the reason inviCRO’s software platforms are relied upon by more than 900 users in more than 175 laboratories across the world, including 70% of the top pharmaceutical companies. These labs use inviCRO’s systems to speed their R&D operations and therefore reduce the time it takes to bring treatments to market.

They offer two integrated software platforms:

  1. VivoQuant™, a DICOM compliant post-processing suite for image data combining fundamental viewing functionality with powerful analysis capabilities. VivoQuant (“VQ”) supports data from most imaging modalities including MR, PET, SPECT, CT, FLECT, EM and Optical
  2. iPACS®, a sophisticated web-based project management system designed for image study management applications. This platform allows for the efficient management, distribution, analysis and presentation of images and data associated with studies. iPACS offers a wide range of functionality for the organizational, processing, reporting and regulatory needs of preclinical and clinical imaging efforts.

“AXT supplies a wide variety of imaging systems that employ a variety of imaging technologies and modalities. These software platforms knit together our existing range and will help Australian medical researchers remain at the head of their field”, said Richard Trett, Managing Director of AXT.

Bill Cupelo from inviCRO also commented, “We recognize Australia’s leading position  in medical research, and we look forward to working with AXT and Australia’s world-class researchers to accelerate their work on drugs, treatments and therapies to fight complex diseases while leveraging our medical image informatics platform.”

Posted April 5, 2016